Results 121 to 130 of about 3,750,451 (195)

Novel antiplatelet agents

open access: yes, 2017
Siasos, G.   +4 more
openaire   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Rationale and design of the BA-SCAD (Beta-blockers and Antiplatelet agents in patients with Spontaneous Coronary Artery Dissection) randomized clinical trial.

Revista Española de Cardiología, 2021
INTRODUCTION Y OBJECTIVES Spontaneous coronary artery dissection (SCAD) is a rare cause of acute coronary syndrome. Most patients are empirically treated with beta-blockers and antiplatelet drugs.
F. Alfonso   +9 more
semanticscholar   +1 more source

Platelet activation and prothrombotic mediators at the nexus of inflammation and atherosclerosis: Potential role of antiplatelet agents.

Blood reviews, 2020
Platelets are central to inflammation-related manifestations of cardiovascular diseases (CVD) such as atherosclerosis. Platelet-activating factor (PAF), thrombin, thromboxane A2 (TxA2), and adenosine diphosphate (ADP) are some of the key agonists of ...
R. Lordan, A. Tsoupras, I. Zabetakis
semanticscholar   +1 more source

Microfluidic assay of antiplatelet agents for inhibition of shear-induced platelet adhesion and activation.

Lab on a Chip, 2020
We have developed a microfluidic system to perfuse whole blood through a flow channel with an upstream stenotic region and a downstream protein capture region.
S. Rahman, V. Hlady
semanticscholar   +1 more source

Treatment of blunt cerebrovascular injuries: Anticoagulants or antiplatelet agents?

Journal of Trauma and Acute Care Surgery, 2020
BACKGROUND Blunt cerebrovascular injury (BCVI) is associated with cerebrovascular accidents (CVA). Early therapy with antiplatelet agents or anticoagulants is recommended. There are limited data comparing the effectiveness of these treatments. The aim of
K. Hanna   +8 more
semanticscholar   +1 more source

Antiplatelet agents

Hematology, 2009
Abstract The introduction of aspirin as an anti-thrombotic agent some 50 years ago has changed the therapeutic approach in cardiovascular medicine. Since platelets play a key role in the development of arterial thrombosis, antiplatelet drugs serve as a cornerstone in the prevention and the treatment of these conditions.
David, Varon, Galia, Spectre
openaire   +2 more sources

New antiplatelet agents

Australian and New Zealand Journal of Medicine, 1998
AbstractAspirin is an established therapy for the management of acute myocardial infarction (AMI) and unstable angina. Secondary prevention with chronic aspirin therapy is also indicated for patients with stable angina.Aspirin inhibits cyclo‐oxygenase‐I, a key enzyme in the biosynthetic pathway leading to the production of thromboxane A2.
H D, White, J K, French, C J, Ellis
openaire   +2 more sources

Home - About - Disclaimer - Privacy